{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:41:30Z","timestamp":1773272490783,"version":"3.50.1"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007273","name":"Weill Cornell Medical College","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007273","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.expneurol.2018.04.001","type":"journal-article","created":{"date-parts":[[2018,4,12]],"date-time":"2018-04-12T20:38:14Z","timestamp":1523565494000},"page":"22-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Attenuation of the Niemann-Pick type C2 disease phenotype by intracisternal administration of an AAVrh.10 vector expressing Npc2"],"prefix":"10.1016","volume":"306","author":[{"given":"Sandra","family":"Markmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmine","family":"J. Christie-Reid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan B.","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bishnu P.","family":"De","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen M.","family":"Kaminsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald G.","family":"Crystal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dolan","family":"Sondhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2018.04.001_bb0005","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/gt.2017.18","article-title":"Efficient CNS targeting in adult mice by intrathecal infusion of single-stranded AAV9-GFP for gene therapy of neurological disorders","volume":"24","author":"Bey","year":"2017","journal-title":"Gene Ther."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0010","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1006\/mthe.1999.0005","article-title":"Long-term and significant correction of brain lesions in adult mucopolysaccharidosis type VII mice using recombinant AAV vectors","volume":"1","author":"Bosch","year":"2000","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0015","first-page":"52","article-title":"Systemic AAV9 gene therapy improves the lifespan of mice with Niemann-Pick disease, type C1","volume":"26","author":"Chandler","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/molecules21121748","article-title":"Cyclodextrins as emerging therapeutic tools in the treatment of cholesterol-associated vascular and neurodegenerative diseases","volume":"21","author":"Coisne","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.expneurol.2018.04.001_bb0025","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s13256-016-1038-9","article-title":"Impact of miglustat on evolution of atypical presentation of late-infantile-onset Niemann-Pick disease type C with early cognitive impairment, behavioral dysfunction, epilepsy, ophthalmoplegia, and cerebellar involvement: a case report","volume":"10","author":"Cuisset","year":"2016","journal-title":"J. Med. Case Rep."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006951","article-title":"Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression","volume":"4","author":"Davidson","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2018.04.001_bb0035","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ymthe.2005.09.003","article-title":"High levels of persistent expression of alpha1-antitrypsin mediated by the nonhuman primate serotype rh.10 adeno-associated virus despite preexisting immunity to common human adeno-associated viruses","volume":"13","author":"De","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0040","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pediatrneurol.2012.04.005","article-title":"Early miglustat therapy in infantile Niemann-Pick disease type C","volume":"47","author":"Di Rocco","year":"2012","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0045","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/sj.gt.3300931","article-title":"Elimination of lysosomal storage in brains of MPS VII mice treated by intrathecal administration of an adeno-associated virus vector","volume":"6","author":"Elliger","year":"1999","journal-title":"Gene Ther."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0050","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13023-015-0240-y","article-title":"Long term follow-up to evaluate the efficacy of miglustat treatment in Italian patients with Niemann-Pick disease type C","volume":"10","author":"Fecarotta","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0055","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2147\/TCRM.S6865","article-title":"Review of miglustat for clinical management in Gaucher disease type 1","volume":"4","author":"Ficicioglu","year":"2008","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0060","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1093\/hmg\/ddm223","article-title":"Functional correction of CNS lesions in an MPS-IIIA mouse model by intracerebral AAV-mediated delivery of sulfamidase and SUMF1 genes","volume":"16","author":"Fraldi","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045992","article-title":"Peripheral nervous system neuropathology and progressive sensory impairments in a mouse model of Mucopolysaccharidosis IIIB","volume":"7","author":"Fu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2018.04.001_bb0070","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ymgme.2013.07.019","article-title":"Efficacy of miglustat in Niemann-Pick C disease: a single centre experience","volume":"110","author":"Ginocchio","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2326409816689786","article-title":"Gene therapy for lysosomal storage disorders: recent advances and limitations","volume":"5","author":"Gonzalez","year":"2017","journal-title":"J. Inborn. Errors Metab. Screen"},{"key":"10.1016\/j.expneurol.2018.04.001_bb0080","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/gt.2012.101","article-title":"Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates","volume":"20","author":"Gray","year":"2013","journal-title":"Gene Ther."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0085","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1172\/JCI66778","article-title":"Whole body correction of mucopolysaccharidosis IIIA by intracerebrospinal fluid gene therapy","volume":"123","author":"Haurigot","year":"2013","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0090","series-title":"Gene Therapy Applications","article-title":"Recent developments in gene therapy research targeted to cerebellar disorders","author":"Hirai","year":"2011"},{"key":"10.1016\/j.expneurol.2018.04.001_bb0095","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1089\/hum.2016.087","article-title":"Adeno-associated virus-based gene therapy for CNS diseases","volume":"27","author":"Hocquemiller","year":"2016","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0100","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac6191","article-title":"AAV gene transfer delays disease onset in a TPP1-deficient canine model of the late infantile form of Batten disease","volume":"7","author":"Katz","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0105","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ana.10366","article-title":"Frontal lobe atrophy due to a mutation in the cholesterol binding protein HE1\/NPC2","volume":"52","author":"Klunemann","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0110","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/gt.2012.99","article-title":"AAV-based gene therapy prevents neuropathology and results in normal cognitive development in the hyperargininemic mouse","volume":"20","author":"Lee","year":"2013","journal-title":"Gene Ther."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0115","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/1440-1681.12285","article-title":"Systemic administration of 2-hydroxypropyl-beta-cyclodextrin to symptomatic Npc1-deficient mice slows cholesterol sequestration in the major organs and improves liver function","volume":"41","author":"Lopez","year":"2014","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0120","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/jnen\/64.4.323","article-title":"Molecular, anatomical, and biochemical events associated with neurodegeneration in mice with Niemann-Pick type C disease","volume":"64","author":"Li","year":"2005","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0125","doi-asserted-by":"crossref","first-page":"9321","DOI":"10.1523\/JNEUROSCI.2936-05.2005","article-title":"Functional correction of CNS phenotypes in a lysosomal storage disease model using adeno-associated virus type 4 vectors","volume":"25","author":"Liu","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0130","article-title":"AAV9-mediated central nervous system-targeted gene delivery via cisterna magna route in mice","volume":"3","author":"Lukashchuk","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0135","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ymgme.2012.11.005","article-title":"Effects of cyclodextrin in two patients with Niemann-Pick Type C disease","volume":"108","author":"Matsuo","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0140","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0006-8993(95)01488-8","article-title":"Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector","volume":"713","author":"McCown","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0145","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.88034","article-title":"Glymphatic fluid transport controls paravascular clearance of AAV vectors from the brain","volume":"1","author":"Murlidharan","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.expneurol.2018.04.001_bb0150","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1126\/science.290.5500.2298","article-title":"Identification of HE1 as the second gene of Niemann-Pick C disease","volume":"290","author":"Naureckiene","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2018.04.001_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027287","article-title":"Protein replacement therapy partially corrects the cholesterol-storage phenotype in a mouse model of Niemann-Pick type C2 disease","volume":"6","author":"Nielsen","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2018.04.001_bb0160","doi-asserted-by":"crossref","first-page":"7034","DOI":"10.1128\/JVI.77.12.7034-7040.2003","volume":"77","author":"Passini","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0165","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1523\/JNEUROSCI.2676-05.2006","article-title":"Intracranial delivery of CLN2 reduces brain pathology in a mouse model of classical late infantile neuronal ceroid lipofuscinosis","volume":"26","author":"Passini","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0170","doi-asserted-by":"crossref","first-page":"26709","DOI":"10.1074\/jbc.M114.586156","article-title":"A novel mouse model of a patient mucolipidosis II mutation recapitulates disease pathology","volume":"289","author":"Paton","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0175","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ymgme.2012.03.012","article-title":"Recommendations for the diagnosis and management of Niemann-Pick disease type C: an update","volume":"106","author":"Patterson","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0180","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1016\/j.febslet.2010.04.047","article-title":"Defective cholesterol trafficking in Niemann-Pick C-deficient cells","volume":"584","author":"Peake","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0185","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1089\/hum.2012.015","article-title":"Correction of brain oligodendrocytes by AAVrh.10 intracerebral gene therapy in metachromatic leukodystrophy mice","volume":"23","author":"Piguet","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0190","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0005-2787(76)90166-0","article-title":"Polyribosome profiles and ribonuclease activity in spleens of normal and anaemic mice","volume":"432","author":"Poels","year":"1976","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.expneurol.2018.04.001_bb0195","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/hmg\/ddu727","article-title":"Biochemical, histological and functional correction of mucopolysaccharidosis type IIIB by intra-cerebrospinal fluid gene therapy","volume":"24","author":"Ribera","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0200","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1093\/hmg\/ddx058","article-title":"Disease correction by AAV-mediated gene therapy in a new mouse model of mucopolysaccharidosis type IIID","volume":"26","author":"Roca","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0205","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1089\/humc.2013.239","article-title":"Comparative efficacy and safety of multiple routes of direct CNS administration of adeno-associated virus gene transfer vector serotype rh.10 expressing the human arylsulfatase A cDNA to nonhuman primates","volume":"25","author":"Rosenberg","year":"2014","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0210","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/cne.10522","article-title":"Patterned Purkinje cell degeneration in mouse models of Niemann-Pick type C disease","volume":"456","author":"Sarna","year":"2003","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0215","doi-asserted-by":"crossref","first-page":"5886","DOI":"10.1073\/pnas.0308456101","article-title":"Genetic evidence for nonredundant functional cooperativity between NPC1 and NPC2 in lipid transport","volume":"101","author":"Sleat","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0220","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00415-016-8051-1","article-title":"Normalisation of brain spectroscopy findings in Niemann-Pick disease type C patients treated with miglustat","volume":"263","author":"Sedel","year":"2016","journal-title":"J. Neurol."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0225","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/hmg\/ddi425","article-title":"Intracerebral adeno-associated virus-mediated gene transfer in rapidly progressive forms of metachromatic leukodystrophy","volume":"15","author":"Sevin","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0230","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12896-014-0094-8","article-title":"A comparison of commercially-available automated and manual extraction kits for the isolation of total RNA from small tissue samples","volume":"14","author":"Sellin Jeffries","year":"2014","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0235","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.omtm.2017.04.006","article-title":"Improved MECP2 gene therapy extends the survival of MeCP2-null mice without apparent toxicity after intracisternal delivery","volume":"5","author":"Sinnett","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0240","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/sj.mt.6300049","article-title":"Enhanced survival of the LINCL mouse following CLN2 gene transfer using the rh.10 rhesus macaque-derived adeno-associated virus vector","volume":"15","author":"Sondhi","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0245","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.expneurol.2008.04.022","article-title":"Survival advantage of neonatal CNS gene transfer for late infantile neuronal ceroid lipofuscinosis","volume":"213","author":"Sondhi","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0250","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1089\/hgtb.2012.120","article-title":"Long-term expression and safety of administration of AAVrh.10hCLN2 to the brain of rats and nonhuman primates for the treatment of late infantile neuronal ceroid lipofuscinosis","volume":"23","author":"Sondhi","year":"2012","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.expneurol.2018.04.001_bb0255","doi-asserted-by":"crossref","first-page":"5518","DOI":"10.1016\/j.febslet.2006.06.008","article-title":"Lipid imbalance in the neurological disorder, Niemann-Pick C disease","volume":"580","author":"Vance","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0260","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10545-014-9794-4","article-title":"Complex lipid trafficking in Niemann-Pick disease type C","volume":"38","author":"Vanier","year":"2015","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0265","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1399-0004.2007.00782.x","article-title":"Niemann-Pick C disease: functional characterization of three NPC2 mutations and clinical and molecular update on patients with NPC2","volume":"71","author":"Verot","year":"2007","journal-title":"Clin. Genet."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0270","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/ana.20392","article-title":"Effective gene therapy for an inherited CNS disease in a large animal model","volume":"57","author":"Vite","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0275","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3010101","article-title":"Intracisternal cyclodextrin prevents cerebellar dysfunction and Purkinje cell death in feline Niemann-Pick type C1 disease","volume":"7","author":"Vite","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-4328(01)00380-1","article-title":"Cognitive deficit and development of motor impairment in a mouse model of Niemann-Pick type C disease","volume":"132","author":"Voikar","year":"2002","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0285","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3389\/fnmol.2016.00067","article-title":"Gene, stem cell, and alternative therapies for SCA 1","volume":"9","author":"Wagner","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0290","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/sj.gt.3302735","article-title":"Intrathecal administration of AAV vectors for the treatment of lysosomal storage in the brains of MPS I mice","volume":"13","author":"Watson","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0295","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jneumeth.2007.09.009","article-title":"Calbindin-D28k is a more reliable marker of human Purkinje cells than standard Nissl stains: a stereological experiment","volume":"168","author":"Whitney","year":"2008","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.expneurol.2018.04.001_bb0300","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1194\/jlr.M500131-JLR200","article-title":"Mannose 6-phosphate receptors, Niemann-Pick C2 protein, and lysosomal cholesterol accumulation","volume":"46","author":"Willenborg","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0305","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbalip.2004.08.011","article-title":"Consequences of NPC1 and NPC2 loss of function in mammalian neurons","volume":"1685","author":"Walkley","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.expneurol.2018.04.001_bb0310","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.bbamcr.2008.11.014","article-title":"Secondary lipid accumulation in lysosomal disease","volume":"1793","author":"Walkley","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.expneurol.2018.04.001_bb0315","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s13023-016-0540-x","article-title":"Fostering collaborative research for rare genetic disease: the example of niemann-pick type C disease","volume":"11","author":"Walkley","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0320","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.nbd.2011.02.015","article-title":"Direct gene transfer to the CNS prevents emergence of neurologic disease in a murine model of mucopolysaccharidosis type I","volume":"43","author":"Wolf","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0325","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1089\/hum.2008.022","article-title":"Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA","volume":"19","author":"Worgall","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0330","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1212\/WNL.0b013e3181e6210e","article-title":"White and gray matter alterations in adults with Niemann-Pick disease type C: a cross-sectional study","volume":"75","author":"Walterfang","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2018.04.001_bb0335","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/mt.2014.68","article-title":"Global CNS transduction of adult mice by intravenously delivered rAAVrh.8 and rAAVrh.10 and nonhuman primates by rAAVrh.10","volume":"22","author":"Yang","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2018.04.001_bb0340","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1089\/humc.2014.139","article-title":"Intracerebral gene therapy using AAVrh.10-hARSA recombinant vector to treat patients with early-onset forms of metachromatic leukodystrophy: preclinical feasibility and safety assessments in nonhuman primates","volume":"26","author":"Zerah","year":"2015","journal-title":"Hum. Gene Ther. Clin. Dev."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488618300840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488618300840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:49:28Z","timestamp":1762148968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488618300840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":68,"alternative-id":["S0014488618300840"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2018.04.001","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Attenuation of the Niemann-Pick type C2 disease phenotype by intracisternal administration of an AAVrh.10 vector expressing Npc2","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2018.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}